Conference Coverage

Tapering TNFi’s safe and much cheaper in RA

Publish date: December 1, 2014

 

AT THE ACR ANNUAL MEETING

References

Dr. van Herwaarden’s study was internally funded. Dr. Yoshida’s study was supported by a grant to Kameda Medical Center, Kamogawa City, Japan. Both physicians reported having no relevant disclosures.

Pages

Recommended Reading

VIDEO: RA linked to increased mortality in Nurses’ Health Study
MDedge Internal Medicine
Novel program improves RA care, cuts costs
MDedge Internal Medicine
Treat-to-target approach cuts mortality risk in RA patients
MDedge Internal Medicine
RA draft guidelines: Treat to target
MDedge Internal Medicine
RA increases mortality, particularly for respiratory causes, in women
MDedge Internal Medicine
VIDEO: Herpes zoster vaccination: Is it safe for rheumatology patients over age 30 on biologics?
MDedge Internal Medicine
VIDEO: Lower heart failure risk seen in users of tumor necrosis factor inhibitors
MDedge Internal Medicine
VIDEO: Collaborative clinic aims at heart of CVD prevention in rheumatic diseases
MDedge Internal Medicine
VIDEO: DAGR may prove to be safer alternative to glucocorticoids
MDedge Internal Medicine
Nonsteroidal ‘DAGR’ looks sharp against RA
MDedge Internal Medicine